Tighter ADR regulations: A boost for Hong Kong

Tighter regulatory scrutiny on Chinese ADRs, amid re-escalating US-China tensions, will accelerate the dual-listing trend into the Hong Kong market. The price impact on existing Chinese ADRs may however be surprisingly muted.

Ken Wong
Client Portfolio Manager

May 2020 | 3 min read

The US Senate passed the Holding Foreign Companies’ Accountable Act on 20 May 2020, tightening regulations on American Depositary Receipts (ADRs). The Act requires companies listed on any of the US securities exchanges to certify that they are not under the control of a foreign government. Companies can also be suspended or delisted if they are unable to comply with the audits by the Public Company Accounting Oversight Board (PCAOB) for three consecutive years.

Thanks for subscribing!

Follow us :

US listings have been a popular way for China’s technology companies to raise capital given the strict restrictions at home. The Act, if it gets passed through Congress and signed by President Trump, could result in Chinese ADRs being delisted from the US stock exchanges as Beijing currently prohibits the PCAOB from inspecting the audit records of China and Hong Kong headquartered companies.

No surprise

The Act should not come as a surprise since discussions on increased disclosure requirements were already underway since last year. The rising US-China geopolitical tensions ahead of the US elections (and post the coronavirus outbreak) as well as the recent accounting scandal at US-listed Lukin Coffee are further catalysts.

A number of US-listed Chinese companies, such as Alibaba, had already turned to secondary listings in Hong Kong last year to broaden their investor bases and reduce risks. The recent passing of the Act in the Senate is likely to compel other companies to do likewise.

Muted impact

There are currently 233 Chinese ADRs listed in the US (primary listings only), with an aggregate listed market capitalisation of USD 1.03 tn. This represents 3.3% of US equity market capitalisation and 8% of all-China market capitalisation.

Among the ADRs, there are about 11 state-owned companies1 which would be impacted if the proposed legislature passes. However, even if some of China’s large state-owned companies such as Petrochina, Sinopec and China Life Insurance are forced to withdraw their ADR listings, the impact is likely to be muted for these companies.

Petrochina’s ADRs, for example, only account for about 1.9% of its outstanding shares with its Hong Kong listing making up for 52.1%. Likewise, for China Life, its ADRs account for only 1.1% of its outstanding shares while its Hong Kong listing makes up 41.3%.

The price impact on the ADRs could also be relatively moderate. It is estimated that US investors hold about USD 350 bn worth of Chinese ADRs, which translates to about one-third of the ADR universe.

Hypothetically, it would take more than 200 days for US investors to fully liquidate their ADR exposures2. If the bill becomes law, there could be a 3-year transition period starting from the date of enactment for affected companies to come into compliance. This transition period could further mitigate the liquidity impact on the market and share prices.

The price impact for some of the state-owned ADRs, could be even more limited given their light trading volumes. Over the past 30 days, for example, the trading value for China Life’s and PetroChina’s ADRs averaged USD 5.6 mn and USD 5.5 mn per day respectively. In contrast, over in Hong Kong for the same duration, the daily trading value for China Life and PetroChina averaged USD 75 mn and USD 36 mn respectively3.

That said, the delisting could pose greater problems for selected technology companies whose US listing accounts for a large percentage of their market capitalisation. Given the potential 3-year transition period, these companies which were listed in 2018 may still have time for potential negotiation/adjustments among related parties.

A boost for Hong Kong

Tighter regulatory scrutiny on Chinese ADRs, against a backdrop of re-escalating US-China tensions is likely to accelerate the dual-listing trend into the Hong Kong market. High profile listings of new economy companies could also lift trading activity. For example, while Alibaba’s Hong Kong listing only account for 0.3% of Hong Kong’s total market capitalisation, it has contributed to 3-4% of the market’s total turnover in the past 90 days4.

It was also announced earlier this week in Hong Kong, that the benchmark Hang Seng Index will for the first time admit companies with secondary listings and multiple classes of voting rights. These reforms, the largest in 14 years, will allow companies such as Alibaba to be included in the index, helping to make Hong Kong a more attractive listing destination for US-listed China technology companies going forward.

The dual-listing trend would be a boost for Hong Kong as the number of Initial Public Offerings (IPOs) has fallen significantly this year. 2020 marks the first time in six years where Hong Kong did not rank among the top three centres globally for IPOs. This may be about to change.

This document is produced by Eastspring Investments (Singapore) Limited and issued in:

Singapore and Australia (for wholesale clients only) by Eastspring Investments (Singapore) Limited (UEN: 199407631H), which is incorporated in Singapore, is exempt from the requirement to hold an Australian financial services licence and is licensed and regulated by the Monetary Authority of Singapore under Singapore laws which differ from Australian laws.

Hong Kong by Eastspring Investments (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Indonesia by PT Eastspring Investments Indonesia, an investment manager that is licensed, registered and supervised by the Indonesia Financial Services Authority (OJK).

Malaysia by Eastspring Investments Berhad (531241-U).

This document is produced by Eastspring Investments (Singapore) Limited and issued in Thailand by TMB Asset Management Co., Ltd. Investment contains certain risks; investors are advised to carefully study the related information before investing. The past performance of any the fund is not indicative of future performance.

United States of America (for institutional clients only) by Eastspring Investments (Singapore) Limited (UEN: 199407631H), which is incorporated in Singapore and is registered with the U.S Securities and Exchange Commission as a registered investment adviser.

European Economic Area (for professional clients only) and Switzerland (for qualified investors only) by Eastspring Investments (Luxembourg) S.A., 26, Boulevard Royal, 2449 Luxembourg, Grand-Duchy of Luxembourg, registered with the Registre de Commerce et des Sociétés (Luxembourg), Register No B 173737.

United Kingdom (for professional clients only) by Eastspring Investments (Luxembourg) S.A. - UK Branch, 10 Lower Thames Street, London EC3R 6AF.

Chile (for institutional clients only) by Eastspring Investments (Singapore) Limited (UEN: 199407631H), which is incorporated in Singapore and is licensed and regulated by the Monetary Authority of Singapore under Singapore laws which differ from Chilean laws.

The afore-mentioned entities are hereinafter collectively referred to as Eastspring Investments.

The views and opinions contained herein are those of the author on this page, and may not necessarily represent views expressed or reflected in other Eastspring Investments’ communications. This document is solely for information purposes and does not have any regard to the specific investment objective, financial situation and/or particular needs of any specific persons who may receive this document. This document is not intended as an offer, a solicitation of offer or a recommendation, to deal in shares of securities or any financial instruments. It may not be published, circulated, reproduced or distributed without the prior written consent of Eastspring Investments. Reliance upon information in this posting is at the sole discretion of the reader. Please consult your own professional adviser before investing. Eastspring Investments and its affiliates may have positions in and may effect transactions in the markets, contracts and related investments different than described in this information.

Investment involves risk. Past performance and the predictions, projections, or forecasts on the economy, securities markets or the economic trends of the markets are not necessarily indicative of the future or likely performance of Eastspring Investments or any of the funds managed by Eastspring Investments.

Information herein is believed to be reliable at time of publication. Data from third party sources may have been used in the preparation of this material and Eastspring Investments has not independently verified, validated or audited such data. Where lawfully permitted, Eastspring Investments does not warrant its completeness or accuracy and is not responsible for error of facts or opinion nor shall be liable for damages arising out of any person’s reliance upon this information. Any opinion or estimate contained in this document may subject to change without notice.

Eastspring Investments (excluding JV companies) companies are ultimately wholly-owned/indirect subsidiaries/associate of Prudential plc of the United Kingdom. Eastspring Investments companies (including JV’s) and Prudential plc are not affiliated in any manner with Prudential Financial, Inc., a company whose principal place of business is in the United States of America or with the Prudential Assurance Company, a subsidiary of M&G plc (a company incorporated in the United Kingdom).